| Upcoming events on ZIMMER BIOMET HOLDINGS |
|
| 02/05/21 | 06:30am | | FY 2020 Earnings Release |
| 02/05/21 | 08:30am | | FY 2020 Earnings Call |
| 04/29/21 | | Q1 2021 Earnings Release (Projected) |
| 07/29/21 | | Interim 2021 Earnings Release (Projected) |
|
| Past events on ZIMMER BIOMET HOLDINGS |
|
| 01/11/21 | 03:40pm | | JP Morgan Healthcare Conference |
| 12/24/20 | | Ex-dividend day for |
| 12/02/20 | 11:00am | | Piper Sandler Health Care Conference |
| 12/01/20 | 10:30am | | Evercore ISI HealthCONx Conference |
|
| Upcoming sector events for ZIMMER BIOMET HOLDINGS |
|
|
| |
|
| Past sector events for ZIMMER BIOMET HOLDINGS |
|
|
|
|
|
| Annual results | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 (e) |
Sales
M $ |
Released
Forecast
Spread | 5 998
6 013
-0,25% | 7 684
7 684
-0,00% | 7 824
7 778
0,59% | 7 933
7 924
0,12% | 7 982
7 962
0,25% |
7 030
|
Operating income
(EBITDA)
M $ |
Released
Forecast
Spread | 2 368
2 353
0,62% | 2 946
2 905
1,4% | 2 896
2 885
0,39% | 2 655
2 666
-0,41% | 2 610
2 642
-1,2% |
2 066
|
Operating profit
(EBIT)
M $ |
Released
Forecast
Spread | 1 993
1 997
-0,18% | 2 473
2 477
-0,16% | 2 437
2 433
0,16% | 2 210
2 203
0,32% | 2 189
2 188
0,00% |
1 624
|
Pre-Tax Profit
(EBT)
M $ |
Released
Forecast
Spread | 12,3
410
-97% | 402
1 117
-64% | 480
857
-44% | -271
1 045
-126% | 906
1 285
-30% |
-94,6
|
Net income
M $ |
Released
Forecast
Spread | 49,7
208
-76% | 303
371
-18% | 1 840
794
132% | -379
827
-146% | 1 132
1 155
-2,1% |
-180
|
EPS
$ |
Released
Forecast
Spread | 0,26
1,24
-79% | 1,50
1,61
-6,5% | 9,03
3,88
133% | -1,86
3,96
-147% | 5,47
5,41
1,1% |
-0,89
| | Announcement Date | 01/28/2016 | 01/31/2017 | 01/30/2018 | 02/01/2019 | 02/04/2020 | |
|
|
|
| Quarterly results | 2018 Q2 | 2018 Q3 | 2018 Q4 | 2019 Q1 | 2019 Q2 | 2019 Q3 | 2019 Q4 | 2020 Q1 | 2020 Q2 | 2020 Q3 | 2020 Q4 (e) | 2021 Q1 (e) | 2021 Q2 (e) | 2021 Q3 (e) | 2021 Q4 (e) |
Sales
M $ |
Released
Forecast
Spread | 2 008
1 994
0,70% | 1 837
1 836
0,06% | 2 071
2 061
0,48% | 1 976
1 966
0,48% | 1 989
1 983
0,28% | 1 892
1 875
0,94% | 2 126
2 107
0,88% | 1 784
1 792
-0,47% | 1 226
922
33% | 1 929
1 714
13% |
2 091
|
1 914
|
1 922
|
2 027
|
2 220
|
Operating income
(EBITDA)
M $ |
Released
Forecast
Spread | 674
675
-0,26% | 584
576
1,5% | 713
721
-1,2% | 629
638
-1,4% | 651
648
0,51% | 606
597
1,4% | 724
733
-1,2% | 572
524
9,1% | 178
24,6
624% | 617
442
40% |
688
|
579
|
642
|
668
|
728
|
Operating profit
(EBIT)
M $ |
Released
Forecast
Spread | 562
551
1,8% | 471
472
-0,22% | 606
603
0,42% | 525
529
-0,78% | 545
538
1,4% | 501
492
1,9% | 617
617
0,11% | 466
422
11% | 69,8
-125
156% | 508
319
59% |
579
|
476
|
511
|
553
|
626
|
Pre-Tax Profit
(EBT)
M $ |
Released
Forecast
Spread | 218
328
-34% | 154
246
-38% | -866
394
-320% | 292
313
-6,8% | 140
336
-58% | 185
289
-36% | 289
410
-29% | -504
192
-362% | -222
-279
20% | 256
31,3
717% |
347
|
304
|
316
|
334
|
417
|
Net income
M $ |
Released
Forecast
Spread | 185
259
-29% | 162
186
-13% | -901
293
-407% | 246
212
16% | 134
272
-51% | 431
233
85% | 321
355
-9,6% | -509
183
-377% | -207
-425
51% | 243
46,5
422% |
292
|
239
|
248
|
282
|
343
|
EPS
$ |
Released
Forecast
Spread | 0,90
1,22
-26% | 0,79
0,90
-13% | -4,42
1,42
-411% | 1,20
1,05
14% | 0,65
1,27
-49% | 2,08
1,11
87% | 1,54
1,67
-7,8% | -2,46
0,85
-389% | -1,00
-1,79
44% | 1,16
0,21
445% |
1,35
|
1,12
|
1,15
|
1,34
|
1,65
| | Announcement Date | 07/27/2018 | 10/26/2018 | 02/01/2019 | 04/26/2019 | 07/26/2019 | 11/05/2019 | 02/04/2020 | 05/11/2020 | 08/04/2020 | 11/06/2020 | | | | | |
|
Financial data source
© 2021 S&P Global Market Intelligence
|
|
© 2021 Factset
|
|
|
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise
|
Canada
Deutschland
España
France
Italia
Schweiz (DE)
United Kingdom
Report
Previous period
